Publication | Open Access

Discovery of trans-3-(pyridin-3-yl)acrylamide-derived sulfamides as potent nicotinamide phosphoribosyltransferase (NAMPT) inhibitors for the potential treatment of cancer

Medicinal ChemistryMedicineNatural SciencesPharmacological AgentPotent Nicotinamide PhosphoribosyltransferasePharmacotherapyAnti-cancer AgentDrug DevelopmentChemical BiologyPharmacologyRadiation OncologyDrug DiscoveryAcrylamide-derived SulfamidesPotential Treatment